Company signals
WinZO
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: This lands while the Talent Market Index reads 114.6 (Hot) — up 16.3 versus the prior month — and Asia signal share is rising (+9.4pts).
WinZO: 1 signal in the last 90 days; 0.2% of MitchelLake's Asia signal flow.
Signals at WinZO
More signals across Asia
Restructuring · Asia
Byju's →BYJU'S founder Byju Raveendran received a stay on jail sentence from Singapore High Court, but the edtech startup remains embroiled in multiple legal proceedings across geographies including US lender claims, Delaware court damages determination, and India insolvency proceedings spanning asset disputes and fund flow scrutiny
Restructuring · Asia
University of Nottingham →University of Nottingham is undergoing significant restructuring with hundreds of redundancies confirmed over next three years, resulting in staff industrial action including strike and marking boycott since June 1.
Restructuring · Asia
WinZO Games →WinZO experiencing severe financial distress with ~130 employees unpaid since January, bank accounts frozen by Enforcement Directorate, and mounting employee exits. Company pivoting to new revenue streams (ZO Play short-form dramas, digital gold, stockbroking) with limited success.
Restructuring · Asia
Bira 91 / B9 Beverages →Bira 91's parent company B9 Beverages faces ₹11.19 Cr legal notice from glass supplier HNGIL over unpaid dues and unlifted inventory. This follows earlier financial and operational challenges including corporate insolvency resolution process (CIRP), licensing issues from name change, and inventory writeoffs. Company is in severe financial distress with mounting supplier disputes.
Restructuring · Asia
Sentoria Group Bhd →Sentoria Group being suspended from Bursa Malaysia and delisted effective June 12-16, 2026 after failing regularisation requirements. Company transitions from public to unlisted status while continuing property development and asset monetisation operations.
Restructuring · Asia
Samsung Biologics →Samsung Biologics experiencing significant labor disputes with ongoing work-to-rule campaign following failed wage negotiations; union demanded 14% wage increase and performance-based pay equivalent to 20% of operating profit while management offered only 6.2%